1. Kirtana, R, Manna, Soumen, Patra, Samir Kumar. 2023. KDM5A noncanonically binds antagonists MLL1/2 to mediate gene regulation and promotes epithelial to mesenchymal transition. In Biochimica et biophysica acta. Gene regulatory mechanisms, 1866, 194986. doi:10.1016/j.bbagrm.2023.194986. https://pubmed.ncbi.nlm.nih.gov/37722486/
2. El Hayek, Lauretta, DeVries, Darlene, Gogate, Ashlesha, Kaur, Kiran, Chahrour, Maria H. 2023. Disruption of the autism gene and chromatin regulator KDM5A alters hippocampal cell identity. In Science advances, 9, eadi0074. doi:10.1126/sciadv.adi0074. https://pubmed.ncbi.nlm.nih.gov/37992166/
3. Xu, Siyuan, Wang, Siqing, Xing, Shenghui, Shi, Zhennan, Lan, Fei. . KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2. In Blood advances, 5, 3241-3253. doi:10.1182/bloodadvances.2020002819. https://pubmed.ncbi.nlm.nih.gov/34448811/
4. Kirtana, R, Manna, Soumen, Patra, Samir Kumar. 2020. Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease. In Experimental cell research, 396, 112314. doi:10.1016/j.yexcr.2020.112314. https://pubmed.ncbi.nlm.nih.gov/33010254/
5. Bertrums, Eline J M, Smith, Jenny L, Harmon, Lauren, Goemans, Bianca F, Meshinchi, Soheil. 2023. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. In Haematologica, 108, 2044-2058. doi:10.3324/haematol.2022.281653. https://pubmed.ncbi.nlm.nih.gov/36815378/
6. El Hayek, Lauretta, Tuncay, Islam Oguz, Nijem, Nadine, Beutler, Bruce, Chahrour, Maria H. 2020. KDM5A mutations identified in autism spectrum disorder using forward genetics. In eLife, 9, . doi:10.7554/eLife.56883. https://pubmed.ncbi.nlm.nih.gov/33350388/
7. Mitsui, Eishin, Yoshida, Shogo, Shinoda, Yui, Sasaki, Ryuzo, Mizukami, Tamio. 2019. Identification of ryuvidine as a KDM5A inhibitor. In Scientific reports, 9, 9952. doi:10.1038/s41598-019-46346-x. https://pubmed.ncbi.nlm.nih.gov/31289306/
8. de Rooij, Jasmijn D E, Branstetter, Cristyn, Ma, Jing, Fornerod, Maarten, Gruber, Tanja A. 2017. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. In Nature genetics, 49, 451-456. doi:10.1038/ng.3772. https://pubmed.ncbi.nlm.nih.gov/28112737/
智鼠故事 
